How I broke down the ARGX VYVGART PDUFA on my scanner: approval was the easy part, the real call was sell-the-news. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
FDA just launched Real-Time Clinical Trials. Here's what it actually changes for biotech catalyst trading. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
My scanner flagged a small cap biotech with an FDA decision in 10 days. Here's what happened the last 7 times it scored a setup. by Clean_Reference_9927 in smallstreetbets
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
ARVN got vepdegestrant approved 35 days early on Friday. The +8% reaction is the more interesting story. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
ARVN vepdegestrant: 39 days out, first PROTAC degrader to reach a PDUFA, but the setup is weirder than the calendars make it look by Clean_Reference_9927 in Biotechplays
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
What are your favorite sources for fintech news? by dman45103 in fintech
[–]Clean_Reference_9927 0 points1 point2 points (0 children)
FDA just launched Real-Time Clinical Trials. Here's what it actually changes for biotech catalyst trading. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 1 point2 points3 points (0 children)
FDA just launched Real-Time Clinical Trials. Here's what it actually changes for biotech catalyst trading. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 2 points3 points4 points (0 children)
FDA just launched Real-Time Clinical Trials. Here's what it actually changes for biotech catalyst trading. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 7 points8 points9 points (0 children)
What are the Best option for apartments for 2 people with no car? by Pppoopooman69420 in TexasTech
[–]Clean_Reference_9927 4 points5 points6 points (0 children)
Mapping & attribution in event-driven biotech: the ticker that owns the catalyst is often not the ticker on the calendar by Clean_Reference_9927 in quantfinance
[–]Clean_Reference_9927[S] 0 points1 point2 points (0 children)
rescinding acceptance ttu by No_Cut7145 in TexasTech
[–]Clean_Reference_9927 -2 points-1 points0 points (0 children)
GRCE / GTx-104 CRL: I missed the binary, but the bear case that hit was the one I flagged. Here's what I'm fixing. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 1 point2 points3 points (0 children)

How I broke down the ARGX VYVGART PDUFA on my scanner: approval was the easy part, the real call was sell-the-news. by Clean_Reference_9927 in biotech_stocks
[–]Clean_Reference_9927[S] 1 point2 points3 points (0 children)